Search clinical trials for: Adalimumab

Total 525 results

AbbVie

Active, not recruiting

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE)

Rheumatoid Arthritis

United States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, ... and more
Janssen Research & Development, LLC

Completed

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment (VOYAGE 2)

Psoriasis

United States, Australia, Poland, Germany, Spain, Korea, Republic of, Canada, Russian Federation, Czechia
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis (COAST-V)

Spondyloarthritis

Taiwan, United States, Korea, Republic of, Germany, Czechia, Japan, Netherlands
AbbVie

Completed

Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

Crohn's Disease
R-Pharm International, LLC
Quintiles, Inc.; OCT Clinical Trials

Completed

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (CREDO 2)

Rheumatoid Arthritis

United States, Germany, Korea, Republic of, Bulgaria, Poland, Taiwan, Mexico, Hungary, Czechia, United Kingdom, Lithuania, Argentina, Brazil, Colombia, Estonia, Latvia, Russian Federation, Romania
Tampere University Hospital

Completed

Prognosis in UC After First Biological (biological)

Ulcerative Colitis
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
St George's, University of London

Completed

Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) (BIORA-PAIN)

Rheumatoid Arthritis

United Kingdom
Amgen

Completed

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States, Poland, Canada, Germany, Estonia, Latvia
Janssen Research & Development, LLC

Terminated

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (LYRA)

Hidradenitis Suppurativa

United States, Germany, Canada, Japan, Netherlands, Spain, Australia, Poland
Biogen

Completed

One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (PERFUSE)

Arthritis, Rheumatoid | Crohn's Disease | Arthritis, Psoriatic | Colitis, Ulcerative | Spondylitis, Ankylosing

France
Wright State University
Wake Forest University Health Sciences; Stanford University

Withdrawn

Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

Pyoderma Gangrenosum

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (RUBI)

Uveitis | Biotherapy

France
Prestige Biopharma Limited

Recruiting

To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects

Healthy Volunteers

Spain
Eli Lilly and Company

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Uveitis

France, Spain, Germany, United Kingdom, Italy
Hoffmann-La Roche

Terminated

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Rheumatoid Arthritis

Germany, Italy, Spain, United States, France, Sweden, Greece, Russian Federation, Denmark, Finland, Netherlands, Puerto Rico
Fresenius Kabi SwissBioSim GmbH
Merck KGaA, Darmstadt, Germany

Completed

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis (AURIEL-PsO)

Psoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type Psoriasis

United States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
Erasmus Medical Center
Merck Sharp & Dohme LLC

Completed

Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Diseases

Netherlands
Eli Lilly and Company

Withdrawn

Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) (SPIRIT A1)

Spondylitis, Ankylosing

Spain, United States, Hungary, Belgium, France, Mexico, Netherlands, Poland, Russian Federation, Ukraine, United Kingdom, Canada, Argentina, Germany, Czech Republic
AbbVie

Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)

Rheumatoid Arthritis

United States, Japan, United Kingdom, Canada, Korea, Republic of, Puerto Rico, South Africa, Hungary, Bulgaria, Spain, Portugal, Chile, Croatia, France, Belgium, Germany, Greece, Romania, Brazil, Italy, Serbia, China
National Institute of Allergy and Infectious Diseases...

Terminated

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
AbbVie

Recruiting

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Juvenile Psoriatic Arthritis

United States
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie

Recruiting

A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab (CONTROL)

Ulcerative Colitis

France
Emergent BioSolutions
Centers for Disease Control and Prevention; Biomedical Advanced Research and...

Completed

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Botulism
Janssen Research & Development, LLC

Completed

A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge

Healthy

Belgium
Hvidovre University Hospital
University Hospital, Gentofte, Copenhagen

Unknown

Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Denmark
MoonLake Immunotherapeutics AG

Active, not recruiting

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

United States, Spain, Bulgaria, Poland, Czechia, Estonia, Germany, Hungary
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Healthy

Korea, Republic of
Keio University
Saitama Medical University

Unknown

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Rheumatoid Arthritis

Japan
Amgen

Completed

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Healthy Volunteers
Janssen Research & Development, LLC

Withdrawn

A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease (DUET)

Crohn Disease

United States
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects

Healthy

Germany
University of Helsinki
AbbVie

Unknown

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis (PETSPA)

Ankylosing Spondyloarthritis

Finland
Tokyo Medical and Dental University

Active, not recruiting

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Crohn Disease

Japan
Foundation for Liver Research

Completed

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's (Adafi)

Crohn's Disease With Perianal Fistulas

Netherlands
University of Padova

Unknown

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy (ELIDACE)

Moderate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.

Italy
Imperial College London

Completed

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

United Kingdom
Centre Hospitalier Universitaire de Saint Etienne
Takeda France

Not yet recruiting

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. (VEDIAN)

Crohn's Disease

France
Vastra Gotaland Region

Recruiting

Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

Inflammatory Bowel Diseases | Ulcerative Colitis

Sweden
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Completed

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
University of Aarhus
Aarhus University Hospital; Abbott; Meda Pharmaceuticals

Completed

Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) (OPERA)

Arthritis, Rheumatoid

Denmark
Biocad

Recruiting

Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

Axial Spondyloarthritis

Russian Federation
Fundación de Investigación Biomédica - Hospital...

Completed

Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells

Inflammatory Bowel Disease
Abbott

Completed

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)

Chronic Plaque Psoriasis

Belgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
AbbVie (prior sponsor, Abbott)

Completed

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

Rheumatoid Arthritis
Abbott

Completed

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Psoriasis

United States, Canada
Eli Lilly and Company

Active, not recruiting

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Juvenile Psoriatic Arthritis | Enthesitis Related Arthritis

Spain, Belgium, Germany, Italy, United Kingdom, Denmark, Mexico, Netherlands, Switzerland
Amgen

Completed

A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

Adalimumab

United States
Alimentiv Inc.

Completed

Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy (REACT2)

Crohn's Disease

United States, United Kingdom, Germany, Canada

Search clinical trials for: Adalimumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations